科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/10 | 3,426 | 3,446 | 3,425 | 3,425 | +5 | +0.1% | 82,400 |
| 2024/04/09 | 3,441 | 3,446 | 3,411 | 3,420 | -22 | -0.6% | 119,200 |
| 2024/04/08 | 3,440 | 3,446 | 3,422 | 3,442 | -3 | -0.1% | 107,500 |
| 2024/04/05 | 3,415 | 3,450 | 3,415 | 3,445 | +30 | +0.9% | 74,900 |
| 2024/04/04 | 3,423 | 3,428 | 3,414 | 3,415 | -8 | -0.2% | 108,800 |
| 2024/04/03 | 3,419 | 3,444 | 3,405 | 3,423 | +4 | +0.1% | 151,300 |
| 2024/04/02 | 3,457 | 3,457 | 3,416 | 3,419 | -48 | -1.4% | 175,500 |
| 2024/04/01 | 3,460 | 3,475 | 3,455 | 3,467 | +8 | +0.2% | 87,800 |
| 2024/03/29 | 3,417 | 3,465 | 3,417 | 3,459 | +43 | +1.3% | 98,100 |
| 2024/03/28 | 3,508 | 3,508 | 3,416 | 3,416 | -170 | -4.7% | 379,600 |
| 2024/03/27 | 3,607 | 3,621 | 3,586 | 3,586 | -9 | -0.3% | 222,500 |
| 2024/03/26 | 3,585 | 3,600 | 3,567 | 3,595 | +4 | +0.1% | 137,200 |
| 2024/03/25 | 3,590 | 3,606 | 3,560 | 3,591 | -13 | -0.4% | 176,900 |
| 2024/03/22 | 3,580 | 3,614 | 3,579 | 3,604 | +44 | +1.2% | 182,300 |
| 2024/03/21 | 3,558 | 3,571 | 3,542 | 3,560 | +9 | +0.3% | 131,100 |
| 2024/03/19 | 3,530 | 3,557 | 3,523 | 3,551 | +12 | +0.3% | 120,500 |
| 2024/03/18 | 3,530 | 3,545 | 3,527 | 3,539 | +15 | +0.4% | 95,000 |
| 2024/03/15 | 3,520 | 3,536 | 3,509 | 3,524 | -5 | -0.1% | 135,400 |
| 2024/03/14 | 3,538 | 3,538 | 3,515 | 3,529 | +8 | +0.2% | 85,000 |
| 2024/03/13 | 3,540 | 3,550 | 3,521 | 3,521 | -23 | -0.6% | 148,400 |
| 2024/03/12 | 3,535 | 3,546 | 3,495 | 3,544 | +5 | +0.1% | 161,000 |
| 2024/03/11 | 3,530 | 3,543 | 3,513 | 3,539 | +16 | +0.5% | 163,800 |
| 2024/03/08 | 3,530 | 3,567 | 3,520 | 3,523 | -55 | -1.5% | 230,000 |
| 2024/03/07 | 3,576 | 3,602 | 3,566 | 3,578 | +13 | +0.4% | 123,200 |
| 2024/03/06 | 3,549 | 3,583 | 3,549 | 3,565 | +11 | +0.3% | 112,300 |
| 2024/03/05 | 3,561 | 3,574 | 3,546 | 3,554 | -7 | -0.2% | 137,000 |
| 2024/03/04 | 3,533 | 3,572 | 3,518 | 3,561 | +28 | +0.8% | 118,800 |
| 2024/03/01 | 3,545 | 3,551 | 3,518 | 3,533 | -18 | -0.5% | 156,400 |
| 2024/02/29 | 3,557 | 3,574 | 3,531 | 3,551 | -8 | -0.2% | 164,000 |
| 2024/02/28 | 3,575 | 3,586 | 3,559 | 3,559 | -16 | -0.4% | 100,200 |
| 2024/02/27 | 3,553 | 3,580 | 3,548 | 3,575 | +23 | +0.6% | 99,800 |
| 2024/02/26 | 3,551 | 3,578 | 3,549 | 3,552 | +11 | +0.3% | 78,100 |
| 2024/02/22 | 3,541 | 3,549 | 3,517 | 3,541 | ±0 | ±0% | 109,400 |
| 2024/02/21 | 3,585 | 3,585 | 3,523 | 3,541 | -43 | -1.2% | 115,000 |
| 2024/02/20 | 3,587 | 3,592 | 3,572 | 3,584 | -4 | -0.1% | 88,300 |
| 2024/02/19 | 3,554 | 3,589 | 3,547 | 3,588 | +50 | +1.4% | 91,200 |
| 2024/02/16 | 3,526 | 3,550 | 3,522 | 3,538 | +33 | +0.9% | 105,600 |
| 2024/02/15 | 3,519 | 3,523 | 3,487 | 3,505 | -14 | -0.4% | 105,800 |
| 2024/02/14 | 3,543 | 3,550 | 3,494 | 3,519 | -24 | -0.7% | 82,000 |
| 2024/02/13 | 3,507 | 3,543 | 3,496 | 3,543 | +37 | +1.1% | 101,500 |
| 2024/02/09 | 3,480 | 3,513 | 3,457 | 3,506 | +9 | +0.3% | 144,300 |
| 2024/02/08 | 3,515 | 3,522 | 3,467 | 3,497 | -14 | -0.4% | 153,800 |
| 2024/02/07 | 3,547 | 3,571 | 3,498 | 3,511 | -19 | -0.5% | 122,400 |
| 2024/02/06 | 3,501 | 3,543 | 3,496 | 3,530 | +29 | +0.8% | 101,300 |
| 2024/02/05 | 3,494 | 3,519 | 3,490 | 3,501 | +7 | +0.2% | 80,200 |
| 2024/02/02 | 3,501 | 3,510 | 3,491 | 3,494 | -6 | -0.2% | 67,400 |
| 2024/02/01 | 3,475 | 3,513 | 3,471 | 3,500 | +10 | +0.3% | 92,000 |
| 2024/01/31 | 3,477 | 3,492 | 3,442 | 3,490 | -1 | ±0% | 106,000 |
| 2024/01/30 | 3,515 | 3,515 | 3,488 | 3,491 | ±0 | ±0% | 64,400 |
| 2024/01/29 | 3,492 | 3,515 | 3,489 | 3,491 | -1 | ±0% | 61,300 |
251～
300
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 409,100円 | +30.5% | +111.0% | 4.64% | 11.53倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 362,200円 | +7.9% | +8.9% | 3.42% | 7.75倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 187,000円 | +5.0% | +1.5% | 0.00% | 16.05倍 | 4.27倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 371,000円 | +14.5% | -2.3% | 2.43% | 13.57倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 239,900円 | - | - | 0.00% | - | 111.12倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
